Chronic, recurrent Lymphocytic Leukemia Not Yet Recruiting Phase 2 Trials for Obinutuzumab (DB08935)
Also known as: Recurrent Chronic Lymphocytic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia) | Not Yet Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|